Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants

Stem Cells and Development

Volumn 21, Issue 15, 2012, Pages 2770-2778

  Lin, Ching Shwun ^a   Lin, Guiting ^a   Lue, Tom F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 17; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROSTAGLANDIN E2;

ADIPOSE DERIVED STEM CELL; ALLERGIC RHINITIS; ALLOIMMUNITY; ALLOTRANSPLANTATION; ANTIBODY RESPONSE; AUTOTRANSPLANTATION; CD8+ T LYMPHOCYTE; CELL CONTACT; CELL DIFFERENTIATION; COMPRESSION FRACTURE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; IMMUNOCOMPETENCE; IMMUNOMODULATION; LIPOSUCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIC PURPURA; TISSUE ENGINEERING; XENOGRAFT; XENOTRANSPLANTATION;

ADIPOSE TISSUE; ANIMALS; CELLS, CULTURED; HUMANS; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE AGENTS; MESENCHYMAL STEM CELL TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

CANIS FAMILIARIS; ORYCTOLAGUS CUNICULUS; RATTUS; SUS;

EID: 84868030244     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0176     Document Type: Review

References (91)

1. da Silva Meirelles L, PC Chagastelles and NB Nardi. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204-2213.
2. Lin CS, ZC Xin, CH Deng, H Ning, G Lin and TF Lue. (2010). Defining adipose tissue-derived stem cells in tissue and in culture. Histol Histopathol 25:807-815.
3. Lin CS, ZC Xin, Z Wang, C Deng, YC Huang, G Lin and TF Lue. (2012). Stem cell therapy for erectile dysfunction: a critical review. Stem Cells Dev 21:343-351.
4. Lin CS and TF Lue. (2012). Adipose-derived stem cells: therapy through paracrine actions. In: Stem Cells and Cancer Stem Cells. Hayat MA, ed. Springer, New York, pp 203-216.
5. Lin CS and TF Lue. (2012). Stem cell therapy for stress urinary incontinence: a critical review. Stem Cells Dev 21: 834-843.
6. Liechty KW, TC MacKenzie, AF Shaaban, A Radu, AM Moseley, R Deans, DR Marshak and AW Flake. (2000). Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6:1282-1286.
7. Devine SM, AM Bartholomew, N Mahmud, M Nelson, S Patil, W Hardy, C Sturgeon, T Hewett, T Chung, et al. (2001). Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 29:244-255.
8. Bartholomew A, C Sturgeon, M Siatskas, K Ferrer, K McIntosh, S Patil, W Hardy, S Devine, D Ucker, et al. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42-48.
9. Saito T, JQ Kuang, B Bittira, A Al-Khaldi and RC Chiu. (2002). Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg 74:19-24; discussion 24.
10. MacDonald DJ, J Luo, T Saito, M Duong, PL Bernier, RC Chiu and D Shum-Tim. (2005). Persistence of marrow stromal cells implanted into acutely infarcted myocardium: observations in a xenotransplant model. J Thorac Cardiovasc Surg 130:1114-1121.
11. Grinnemo KH, A Mansson, G Dellgren, D Klingberg, E Wardell, V Drvota, C Tammik, J Holgersson, O Ringden, C Sylven and K Le Blanc. (2004). Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J Thorac Cardiovasc Surg 127: 1293-1300.
12. Grinnemo KH, A Mansson-Broberg, K Leblanc, M Corbascio, E Wardell, AJ Siddiqui, X Hao, C Sylven and G Dellgren. (2006). Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel. Ann Med 38:144-153.
13. Krampera M, S Glennie, J Dyson, D Scott, R Laylor, E Simpson and F Dazzi. (2003). Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigenspecific T cells to their cognate peptide. Blood 101:3722-3729.
14. Di Nicola M, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, P Matteucci, S Grisanti and AM Gianni. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843.
15. Tse WT, JD Pendleton, WM Beyer, MC Egalka and EC Guinan. (2003). Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75:389-397.
16. Kim HJ, JB Park, JK Lee, EY Park, EA Park, KD Riew and SK Rhee. (2008). Transplanted xenogenic bone marrow stem cells survive and generate new bone formation in the posterolateral lumbar spine of non-immunosuppressed rabbits. Eur Spine J 17:1515-1521.
17. Paul A, S Srivastava, G Chen, D Shum-Tim and S Prakash. (2012). Functional assessment of adipose stem cells for xenotransplantation using myocardial infarction immunocompetent models: comparison with bone marrow stem cells. Cell Biochem Biophys [Epub ahead of print]; DOI: 10.1007/s12013-011-9323- 0.
18. Pal R, C Gopinath, NM Rao, P Banerjee, V Krishnamoorthy, NK Venkataramana and S Totey. (2010). Functional recovery after transplantation of bone marrow-derived human mesenchymal stromal cells in a rat model of spinal cord injury. Cytotherapy 12:792-806.
19. Guan M, W Yao, R Liu, KS Lam, J Nolta, J Jia, B Panganiban, L Meng, P Zhou, et al. (2012). Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med 18:456-462.
20. Lin G, M Garcia, H Ning, L Banie, YL Guo, TF Lue and CS Lin. (2008). Defining stem and progenitor cells within adipose tissue. Stem Cells Dev 17:1053-1063.
21. da Silva Meirelles L, TT Sand, RJ Harman, DP Lennon and AI Caplan. (2009). MSC frequency correlates with blood vessel density in equine adipose tissue. Tissue Eng Part A 15:221-229.
22. Ergun S, D Tilki and D Klein. (2011). Vascular wall as a reservoir for different types of stem and progenitor cells. Antioxid Redox Signal 15:981-995.
23. Corselli M, CW Chen, B Sun, S Yap, JP Rubin and B Peault. (2012). The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev 21:1299-1308.
24. Crandall DL, GJ Hausman and JG Kral. (1997). A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4: 211-232.
25. Housman TS, N Lawrence, BG Mellen, MN George, JS Filippo, KA Cerveny, M DeMarco, SR Feldman and AB Fleischer. (2002). The safety of liposuction: results of a national survey. Dermatol Surg 28:971-978.
26. Strem BM, KC Hicok, M Zhu, I Wulur, Z Alfonso, RE Schreiber, JK Fraser and MH Hedrick. (2005). Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 54:132-141.
27. Guven S, M Karagianni, M Schwalbe, S Schreiner, J Farhadi, S Bula, K Bieback, I Martin and A Scherberich. (2012). Validation of an automated procedure to isolate human adipose tissue-derived cells by using the Sepax technology. Tissue Eng Part C Methods. [Epub ahead of print]; DOI: 10.1089/ten.tec.2011.0617.
28. Lin K, YMatsubara, YMasuda, K Togashi, T Ohno, T Tamura, Y Toyoshima, K Sugimachi, M Toyoda, H Marc and A Douglas. (2008). Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy 10:417-426.
29. Puissant B, C Barreau, P Bourin, C Clavel, J Corre, C Bousquet, C Taureau, B Cousin, M Abbal, et al. (2005). Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129:118-129.
30. Wolbank S, A Peterbauer, M Fahrner, S Hennerbichler, M van Griensven, G Stadler, H Redl and C Gabriel. (2007). Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13:1173-1183.
31. Cui L, S Yin, W Liu, N Li, W Zhang and Y Cao. (2007). Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng 13:1185-1195.
32. McIntosh K, S Zvonic, S Garrett, JB Mitchell, ZE Floyd, L Hammill, A Kloster, Y Di Halvorsen, JP Ting, et al. (2006). The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 24:1246-1253.
33. Yanez R, ML Lamana, J Garcia-Castro, I Colmenero, M Ramirez and JA Bueren. (2006). Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 24:2582-2591.
34. Keyser KA, KE Beagles and HP Kiem. (2007). Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation. Cell Transplant 16:555-562.
35. Yoo KH, IK Jang, MW Lee, HE Kim, MS Yang, Y Eom, JE Lee, YJ Kim, SK Yang, et al. (2009). Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol 259:150-156.
36. DelaRosa O, E Lombardo, A Beraza, P Mancheno-Corvo, C Ramirez, R Menta, L Rico, E Camarillo, L Garcia, et al. (2009). Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. Tissue Eng Part A 15:2795-2806.
37. Niemeyer P, M Kornacker, A Mehlhorn, A Seckinger, J Vohrer, H Schmal, P Kasten, V Eckstein, NP Sudkamp and U Krause. (2007). Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. Tissue Eng 13:111-121.
38. Djouad F, LM Charbonnier, C Bouffi, P Louis-Plence, C Bony, F Apparailly, C Cantos, C Jorgensen and D Noel. (2007). Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25:2025-2032.
39. Kang JW, KS Kang, HC Koo, JR Park, EW Choi and YH Park. (2008). Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derived mesenchymal stem cells. Stem Cells Dev 17:681-693.
40. Najar M, G Raicevic, HI Boufker, H Fayyad Kazan, C De Bruyn, N Meuleman, D Bron, M Toungouz and L Lagneaux. (2010). Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources. Cell Immunol 264:171-179.
41. Yanez R, A Oviedo, M Aldea, JA Bueren and ML Lamana. (2010). Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissuederived mesenchymal stromal cells. Exp Cell Res 316: 3109-3123.
42. Najar M, G Raicevic, HI Boufker, H Fayyad-Kazan, C De Bruyn, N Meuleman, D Bron, M Toungouz and L Lagneaux. (2010). Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. Tissue Eng Part A 16:3537-3546.
43. Ivanova-Todorova E, I Bochev, M Mourdjeva, R Dimitrov, D Bukarev, S Kyurkchiev, P Tivchev, I Altunkova and DS Kyurkchiev. (2009). Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells. Immunol Lett 126:37-42.
44. Gonzalez-Rey E, MA Gonzalez, N Varela, F O'Valle, P Hernandez-Cortes, L Rico, D Buscher and M Delgado. (2010). Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis 69:241-248.
45. Kuo YR, CC Chen, S Goto, IT Lee, CW Huang, CC Tsai, CT Wang and CL Chen. (2011). Modulation of immune response and T-cell regulation by donor adipose-derived stem cells in a rodent hind-limb allotransplant model. Plast Reconstr Surg 128:661e-672e.
46. Lubberts E. (2008). IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? Cytokine 41:84-91.
47. Pernis AB. (2009). Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J Intern Med 265:644-652.
48. Lai K, K Zeng, F Zeng, J Wei and G Tan. (2011). Allogeneic adipose-derived stem cells suppress Th17 lymphocytes in patients with active lupus in vitro. Acta Biochim Biophys Sin (Shanghai) 43:805-812.
49. Crop MJ, SS Korevaar, R de Kuiper, JN Ijzermans, NM van Besouw, CC Baan, W Weimar and MJ Hoogduijn. (2011). Human mesenchymal stem cells are susceptible to lysis by CD8 + T-cells and NK cells. Cell Transplant 20:1547-1559.
50. Crop MJ, CC Baan, SS Korevaar, JN Ijzermans, W Weimar and MJ Hoogduijn. (2010). Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation. Stem Cells Dev 19:1843-1853.
51. Fang B, YP Song, LM Liao, Q Han and RC Zhao. (2006). Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells. Bone Marrow Transplant 38:389-390.
52. Fang B, Y Song, RC Zhao, Q Han and Q Lin. (2007). Using human adipose tissue-derived mesenchymal stem cells as salvage therapy for hepatic graft-versus-host disease resembling acute hepatitis. Transplant Proc 39:1710-1713.
53. Fang B, Y Song, Q Lin, Y Zhang, Y Cao, RC Zhao and Y Ma. (2007). Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children. Pediatr Transplant 11:814-817.
54. Fang B, Y Song, L Liao, Y Zhang and RC Zhao. (2007). Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graftversus-host disease. Transplant Proc 39:3358-3362.
55. Fang B, YP Song, N Li, J Li, Q Han and RC Zhao. (2009). Resolution of refractory chronic autoimmune thrombocytopenic purpura following mesenchymal stem cell transplantation: a case report. Transplant Proc 41:1827-1830.
56. Fang B, Y Song, N Li, J Li, Q Han and RC Zhao. (2009). Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation. Ann Hematol 88:261-266.
57. Ryu HH, JH Lim, YE Byeon, JR Park, MS Seo, YW Lee, WH Kim, KS Kang and OK Kweon. (2009). Functional recovery and neural differentiation after transplantation of allogenic adipose-derived stem cells in a canine model of acute spinal cord injury. J Vet Sci 10:273-284.
58. Lopez MJ, KR McIntosh, ND Spencer, JN Borneman, R Horswell, P Anderson, G Yu, L Gaschen and JM Gimble. (2009). Acceleration of spinal fusion using syngeneic and allogeneic adult adipose derived stem cells in a rat model. J Orthop Res 27:366-373.
59. McIntosh KR, MJ Lopez, JN Borneman, ND Spencer, PA Anderson and JM Gimble. (2009). Immunogenicity of allogeneic adipose-derived stem cells in a rat spinal fusion model. Tissue Eng Part A 15:2677-2686.
60. Cho KS, HK Park, HY Park, JS Jung, SG Jeon, YK Kim and HJ Roh. (2009). IFATS collection: immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model. Stem Cells 27:259-265.
61. Kang SK, DH Lee, YC Bae, HK Kim, SY Baik and JS Jung. (2003). Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol 183:355-366.
62. Rodriguez AM, D Pisani, CA Dechesne, C Turc-Carel, JY Kurzenne, B Wdziekonski, A Villageois, C Bagnis, JP Breittmayer, et al. (2005). Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med 201:1397-1405.
63. Kim U, DG Shin, JS Park, YJ Kim, SI Park, YM Moon and KS Jeong. (2011). Homing of adipose-derived stem cells to radiofrequency catheter ablated canine atrium and differentiation into cardiomyocyte-like cells. Int J Cardiol 146: 371-378.
64. Niemeyer P, J Vohrer, H Schmal, P Kasten, J Fellenberg, NP Suedkamp and AT Mehlhorn. (2008). Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice. Cytotherapy 10:784-795.
65. Kang HM, J Kim, S Park, H Kim, KS Kim, EJ Lee, SI Seo, SG Kang, JE Lee and H Lim. (2009). Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice. Stem Cells 27:1999-2008.
66. Black LL, J Gaynor, C Adams, S Dhupa, AE Sams, R Taylor, S Harman, DA Gingerich and R Harman. (2008). Effect of intraarticular injection of autologous adipose-derived mesenchymal stem and regenerative cells on clinical signs of chronic osteoarthritis of the elbow joint in dogs. Vet Ther 9:192-200.
67. Black LL, J Gaynor, D Gahring, C Adams, D Aron, S Harman, DA Gingerich and R Harman. (2007). Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. Vet Ther 8:272-284.
68. Guercio A, P Di Marco, S Casella, V Cannella, L Russotto, G Purpari, S Di Bella and G Piccione. (2012). Production of canine mesenchymal stem cells from adipose tissue and their application in dogs with chronic osteoarthritis of the humeroradial joints. Cell Biol Int 36:189-194.
69. Schuurman HJ. (2008). Regulatory aspects of pig-to-human islet transplantation. Xenotransplantation 15:116-120.
70. Cooper DK. (2012). A brief history of cross-species organ transplantation. Proc (Bayl Univ Med Cent) 25:49-57.
71. Kim JM, ST Lee, K Chu, KH Jung, EC Song, SJ Kim, DI Sinn, JH Kim, DK Park, et al. (2007). Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res 1183:43-50.
72. Fatar M, M Stroick, M Griebe, I Marwedel, S Kern, K Bieback, FL Giesel, C Zechmann, S Kreisel, et al. (2008). Lipoaspirate-derived adult mesenchymal stem cells improve functional outcome during intracerebral hemorrhage by proliferation of endogenous progenitor cells stem cells in intracerebral hemorrhages. Neurosci Lett 443:174-178.
73. Arnalich-Montiel F, S Pastor, A Blazquez-Martinez, J Fernandez-Delgado, M Nistal, JL Alio and MP De Miguel. (2008). Adipose-derived stem cells are a source for cell therapy of the corneal stroma. Stem Cells 26:570-579.
74. Plaschke K. (2009). Human adult mesenchymal stem cells improve rat spatial cognitive function after systemic hemorrhagic shock. Behav Brain Res 201:332-337.
75. Zhu XY, XZ Zhang, L Xu, XY Zhong, Q Ding and YX Chen. (2009). Transplantation of adipose-derived stem cells overexpressing hHGF into cardiac tissue. Biochem Biophys Res Commun 379:1084-1090.
76. Gonzalez MA, E Gonzalez-Rey, L Rico, D Buscher and M Delgado. (2009). Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136:978-989.
77. Gonzalez-Rey E, P Anderson, MA Gonzalez, L Rico, D Buscher and M Delgado. (2009). Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58:929-939.
78. Gonzalez MA, E Gonzalez-Rey, L Rico, D Buscher and M Delgado. (2009). Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 60:1006-1019.
79. Li K, Q Han, X Yan, L Liao and RC Zhao. (2010). Not a process of simple vicariousness, the differentiation of human adipose-derived mesenchymal stem cells to renal tubular epithelial cells plays an important role in acute kidney injury repairing. Stem Cells Dev 19:1267-1275.
80. Keibl C, A Fugl, G Zanoni, S Tangl, S Wolbank, H Redl and M van Griensven. (2011). Human adipose derived stem cells reduce callus volume upon BMP-2 administration in bone regeneration. Injury 42:814-820.
81. Zhou B, J Yuan, Y Zhou, M Ghawji, Jr., YP Deng, AJ Lee, U Nair, AH Kang, DD Brand and TJ Yoo. (2011). Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis. Clin Immunol 141:328-337.
82. Zhou Y, J Yuan, B Zhou, AJ Lee, M Ghawji, Jr. and TJ Yoo. (2011). The therapeutic efficacy of human adipose tissuederived mesenchymal stem cells on experimental autoimmune hearing loss in mice. Immunology 133:133-140.
83. Kim JH, DJ Park, JC Yun, MH Jung, HD Yeo, HJ Kim, DW Kim, JI Yang, GW Lee, et al. (2012). Human adipose tissuederived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats. Am J Physiol Renal Physiol 302:F1141-F1150.
84. Choi EW, IS Shin, SY Park, JH Park, JS Kim, EJ Yoon, SK Kang, JC Ra and SH Hong. (2012). Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation. Arthritis Rheum 64:243-253.
85. Liu Y, X Yan, Z Sun, B Chen, Q Han, J Li and RC Zhao. (2007). Flk-1 + adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice. Stem Cells Dev 16:695-706.
86. Cho HH, YJ Kim, JT Kim, JS Song, KK Shin, YC Bae and JS Jung. (2009). The role of chemokines in proangiogenic action induced by human adipose tissue-derived mesenchymal stem cells in the murine model of hindlimb ischemia. Cell Physiol Biochem 24:511-518.
87. Yang Z, K Li, X Yan, F Dong and C Zhao. (2010). Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats. Graefes Arch Clin Exp Ophthalmol 248:1415-1422.
88. Hwangbo S, J Kim, S Her, H Cho and J Lee. (2010). Therapeutic potential of human adipose stem cells in a rat myocardial infarction model. Yonsei Med J 51:69-76.
89. Jeong JH, JH Lee, ES Jin, JK Min, SR Jeon and KH Choi. (2010). Regeneration of intervertebral discs in a rat disc degeneration model by implanted adipose-tissue-derived stromal cells. Acta Neurochir (Wien) 152:1771-1777.
90. Xuqian W, L Kanghua, Y Weihong, Y Xi, D Rongping, H Qin, D Fangtian and R Chunhua Zhao. (2011). Intraocular transplantation of human adipose-derived mesenchymal stem cells in a rabbit model of experimental retinal holes. Ophthalmic Res 46:199-207.
91. Xiao J, C Zhang, Y Zhang, X Zhang, J Zhao, J Liang, X Zhong and Y Chen. (2012). Transplantation of adiposederived mesenchymal stem cells into a murine model of passive chronic immune thrombocytopenia. Transfusion [Epub ahead of print]; DOI: 10.1111/j.1537-2995.2012. 03642.x.